Dibrospidium chloride

Source: Wikipedia, the free encyclopedia.
Dibrospidium chloride
INN: Dibrospidium chloride
Clinical data
Other namesSpirobromin, spirobromine
ATC code
Identifiers
  • 3,12-Bis(3-bromopropanoyl)-3,6,9,12-tetraazadispiro[5.2.5~9~.2~6~]hexadecane-6,9-diium dichloride
JSmol)
  • [Cl-].[Cl-].BrCCC(=O)N1CC[N+]2(CC1)CC[N+]3(CCN(CC3)C(=O)CCBr)CC2
  • InChI=InChI=1S/C18H32Br2N4O2.2ClH/c19-3-1-17(25)21-5-9-23(10-6-21)13-15-24(16-14-23)11-7-22(8-12-24)18(26)2-4-20;;/h1-16H2;2*1H/q+2;;/p-2
  • Key:CURYRIVJTBNEGU-UHFFFAOYSA-L

Dibrospidium chloride, also known as spirobromin, is a drug being investigated to treat

anti-neoplastic properties. It is an alkylating antineoplastic agent.[1][2]

Dibrospidium chloride and related compounds were developed in Russia in the 1980s.[3][4] It is currently used in Russia as a cytostatic antitumor chemotherapeutic drug.[5]

References

  1. ^ Chambers M. "CAS - 86641-76-1 - CURYRIVJTBNEGU-UHFFFAOYSA-L - Dibrospidium chloride [INN]". ChemIDplus. U.S. National Library of Medicine. Retrieved 25 May 2022.
  2. ^ "Dibrospidium Chloride". PubChem. U.S. National Library of Medicine. Retrieved 25 May 2022.
  3. S2CID 43730360
    .
  4. S2CID 9795933
    .
  5. S2CID 226300593
    .
drug article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Dibrospidium_chloride&oldid=1149946439"